Nick joined CSIRO in 2008 as a Business Development Manager for the Mathematics, Informatics and Statistics division, where he negotiated and secured a number of licence agreements with a range of organisations, including a multi-million dollar licence to a prominent multinational for access to valuable CSIRO technology in the area of foreign exchange exotic options trading. In addition, he has negotiated numerous research consultancy agreements and been responsible for the generation of significant new business for the organisation. Nick moved across to the commercialisation team at the start of 2010, and works primarily in the Information Sciences Group. In this role, Nick has been successful in closing a range of licensing transactions, whereby CSIRO technology is licensed to both Australian and multinational organisations, providing commercial returns to CSIRO and providing benefit to Australia by distributing CSIRO-developed IP as broadly as possible. Prior to joining CSIRO, Nick spent 3 years with the University of Technology, Sydney (UTS) commercialisation team, and for the last year led the team as Executive Manager, Industry Engagement and Commercialisation. Nick was responsible for negotiation of commercial terms for all research agreements for the university, and for leading and managing all commercialisation activities, including negotiation of licences for university intellectual property to industry. He was also responsible for the whole IP portfolio of the university, making all decisions relating to filing and prosecution of university patents and trademarks. Prior to this, Nick had 5 years commercialisation consulting experience with a leading Australian innovation commercialisation consulting firm, SCP Technology and Growth Pty Ltd, where he was involved in a wide range of commercialisation activities, from licensing transactions and the formation of start-up companies through to listing companies on the ASX. Some examples include Sunshine Heart Company Pty Ltd, which involved the formation of the company, securing millions of dollars in government grants, securing significant venture capital investment, and eventually listing the company on the ASX. Nick was also involved in listing BioMD (now Allied Healthcare Group) on the ASX. Nick holds a Master of Science and Technology Commercialisation from the University of Adelaide.